Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
Status:
Unknown status
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether obese people do not respond to hepatitis C
treatment as well as lean people. This research studies whether obese people will show
higher sustained virologic response rate if they lose weight by Orlistat use and dietary and
lifestyle modification.